207 related articles for article (PubMed ID: 26444655)
1. T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection.
Brunet M; Millán López O; López-Hoyos M
Ther Drug Monit; 2016 Apr; 38 Suppl 1():S21-8. PubMed ID: 26444655
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-based immune monitoring.
Millán O; Brunet M
Clin Biochem; 2016 Mar; 49(4-5):338-46. PubMed ID: 26800778
[TBL] [Abstract][Full Text] [Related]
3. Cytokines as predictive biomarkers of alloreactivity.
Brunet M
Clin Chim Acta; 2012 Sep; 413(17-18):1354-8. PubMed ID: 22561186
[TBL] [Abstract][Full Text] [Related]
4. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.
Boix F; Millan O; San Segundo D; Mancebo E; Rimola A; Fabrega E; Fortuna V; Mrowiec A; Castro-Panete MJ; Peña Jde L; Llorente S; Minguela A; Bolarin JM; Paz-Artal E; Lopez-Hoyos M; Brunet M; Muro M
Immunobiology; 2016 May; 221(5):595-603. PubMed ID: 26850323
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
Bestard O; Cruzado JM; Lucia M; Crespo E; Casis L; Sawitzki B; Vogt K; Cantarell C; Torras J; Melilli E; Mast R; Martinez-Castelao A; Gomà M; Reinke P; Volk HD; Grinyó JM
Kidney Int; 2013 Dec; 84(6):1226-36. PubMed ID: 23783240
[TBL] [Abstract][Full Text] [Related]
6. Markers of acute rejection and graft acceptance in liver transplantation.
Germani G; Rodriguez-Castro K; Russo FP; Senzolo M; Zanetto A; Ferrarese A; Burra P
World J Gastroenterol; 2015 Jan; 21(4):1061-8. PubMed ID: 25632178
[TBL] [Abstract][Full Text] [Related]
7. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.
Millán O; Urtasun N; Brunet M
Transplant Rev (Orlando); 2009 Apr; 23(2):120-8. PubMed ID: 19298943
[TBL] [Abstract][Full Text] [Related]
9. Propagation and characterization of lymphocytes from transplant biopsies.
Duquesnoy RJ; Trager JD; Zeevi A
Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
[TBL] [Abstract][Full Text] [Related]
10. Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.
Brunet M; Shipkova M; van Gelder T; Wieland E; Sommerer C; Budde K; Haufroid V; Christians U; López-Hoyos M; Barten MJ; Bergan S; Picard N; Millán López O; Marquet P; Hesselink DA; Noceti O; Pawinski T; Wallemacq P; Oellerich M
Ther Drug Monit; 2016 Apr; 38 Suppl 1():S1-20. PubMed ID: 26977997
[TBL] [Abstract][Full Text] [Related]
11. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of ginsenoside-Rd on skin allograft rejection in rats.
Wang L; Zhang Y; Chen J; Li S; Wang Y; Hu L; Wang L; Wu Y
J Surg Res; 2012 Jul; 176(1):267-74. PubMed ID: 21872268
[TBL] [Abstract][Full Text] [Related]
13. Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients.
Millán O; Rafael-Valdivia L; Torrademé E; López A; Fortuna V; Sánchez-Cabus S; López-Púa Y; Rimola A; Brunet M
Cytokine; 2013 Feb; 61(2):556-64. PubMed ID: 23265966
[TBL] [Abstract][Full Text] [Related]
14. Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients.
van der Zwan M; Hesselink DA; Clahsen-van Groningen MC; Baan CC
Ther Drug Monit; 2019 Apr; 41(2):243-248. PubMed ID: 30883517
[TBL] [Abstract][Full Text] [Related]
15. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA.
Normann SJ; Peck AB; Staples ED; Salomon DR; Mills RM
J Heart Lung Transplant; 1996 Aug; 15(8):778-89. PubMed ID: 8878760
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte markers and prediction of long-term renal allograft acceptance.
Babel N; Reinke P; Volk HD
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
[TBL] [Abstract][Full Text] [Related]
17. Luteolin attenuates acute liver allograft rejection in rats by inhibiting T cell proliferation and regulating T cell subsets.
Wang H; Li C; Xiong Z; Li T
Int Immunopharmacol; 2023 Aug; 121():110407. PubMed ID: 37290328
[TBL] [Abstract][Full Text] [Related]
18. Acute lung transplant rejection is associated with localized increase in T-cell IFNgamma and TNFalpha proinflammatory cytokines in the airways.
Hodge G; Hodge S; Chambers D; Reynolds PN; Holmes M
Transplantation; 2007 Dec; 84(11):1452-8. PubMed ID: 18091521
[TBL] [Abstract][Full Text] [Related]
19. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
[TBL] [Abstract][Full Text] [Related]
20. Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients.
Hodge G; Hodge S; Li-Liew C; Reynolds PN; Holmes M
Respirology; 2012 Jan; 17(1):155-63. PubMed ID: 21995313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
